Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.8K
4.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC).

Future oncology (London, England)·2026
Same author

Comparative Efficacy of Belantamab Mafodotin in Combination With Bortezomib and Dexamethasone Versus Standards of Care in Patients With Third-Line or Later Relapsed/Refractory Multiple Myeloma.

American journal of hematology·2026
Same author

The Impact of Robotics on Procedural Flow and Surgeon Strain in Total Knee Arthroplasty.

Journal of patient safety·2026
Same author

Impact of Diffusing Lung Capacity for Carbon Monoxide on Mortality Risk in Patients with ASMD: Insights from a Post Hoc Analysis.

Advances in therapy·2026
Same author

Single-Particle Entanglement Dynamics in Complex Systems.

Entropy (Basel, Switzerland)·2026
Same author

Point-of-care ultrasonography in assessment of fluid status in children with acute kidney injury: clinical implications and limitations.

Pediatric nephrology (Berlin, Germany)·2026

Related Experiment Video

Updated: Apr 21, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

6.5K

Rhabdomyosarcoma infiltrating bone marrow.

Kriti Chauhan1, Monica Jain, Pragya Shukla

  • 1Department of Oncopathology, Delhi State Cancer Institute, Dilshad Garden, Delhi, 110095, India.

International Journal of Hematology
|October 29, 2014
PubMed
Summary
This summary is machine-generated.

This case study details a rhabdomyosarcoma (RMS) diagnosis in a young male, highlighting its unique presentation and diagnostic markers. Immunohistochemistry confirmed RMS, differentiating it from acute leukemia.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 21, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

6.5K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.0K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.5K

Area of Science:

  • Oncology
  • Hematopathology
  • Diagnostic Pathology

Background:

  • Rhabdomyosarcoma (RMS) is a rare soft tissue sarcoma, often presenting in pediatric patients, but can occur in adults.
  • Perineal rhabdomyosarcoma is an uncommon subtype requiring careful diagnostic evaluation.
  • Distinguishing RMS from other bone marrow malignancies, such as acute leukemia, is crucial for appropriate treatment.

Observation:

  • A 26-year-old male with a known perineal rhabdomyosarcoma presented with a leukoerythroblastic peripheral blood smear.
  • Bone marrow aspirate and biopsy revealed monotonous sheets of malignant cells.
  • Immunohistochemistry showed tumor cells strongly positive for desmin and negative for CD34 and CD117.

Findings:

  • The morphological and immunohistochemical findings are consistent with rhabdomyosarcoma.
  • The absence of CD34 and CD117 expression helps exclude myeloid neoplasms.
  • The leukoerythroblastic picture in peripheral blood can be seen in RMS with bone marrow involvement.

Implications:

  • This case underscores the importance of comprehensive diagnostic workup for suspected bone marrow involvement in RMS.
  • Immunohistochemical markers, including CD34 and CD117, are vital for differential diagnosis, particularly to rule out acute leukemia.
  • Accurate diagnosis through detailed morphology and specific immunostains is essential for guiding therapeutic strategies in rhabdomyosarcoma.